topics therapeutic-services 
Herbert Smith Freehills
JUNE 11, 2023
Leading international law firm Herbert Smith Freehills has advised the sole sponsor and the overall coordinators on Cutia Therapeutics (02487.HK)'s Cutia Therapeutics is an R&D-driven, dermatology-focused biopharmaceutical company. Cutia Therapeutics listed on 12 June 2023. "We
SpicyIP
JANUARY 2, 2022
This year, we have divided these developments into three categories: a) Top 10 IP Judgments/Orders (Topicality/Impact). Top 10 Judgments/Orders [Topicality/Impact]. b) Top 10 IP Judgments/Orders (Jurisprudence/Legal Lucidity) and. c) Top 10 Other IP Developments. H Lundbeck A/S v. Hetero Drugs Ltd [Delhi High Court].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
LexBlog IP
MARCH 12, 2023
.” Judge John Koeltl’s sixty-three page opinion focused on, among other things, Gateguard’s terms of service agreement which specifically forbid reverse engineering. Regor Therapeutics, Inc. Are communications with the FBI about an opposing party privileged? pending in the U.S. District Court of Connecticut.
Fish & Richardson Trademark & Copyright Thoughts
JANUARY 11, 2022
Department of Health & Human Services (HHS) released its Comprehensive Plan for Addressing High Drug Prices. The Federal Circuit addressed written description in Juno Therapeutics, Inc. Tackling Biologic Drug Pricing. On September 9, 2021, the U.S. The Plan is replete with suggestions that involve or impact biosimilars. 9,765,342).
LexBlog IP
DECEMBER 31, 2022
“These types of models can enable fast evaluation of medical device settings and patient-selection criteria, as well as the development of novel therapeutic agents,” she explained. The National Library of Medicine (NLM) has also reported on the topic of AI in radiotherapy , where AI can be applied to images (e.g.,
Expert insights. Personalized for you.
52 
Let's personalize your content